Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Faculdade de Medicina de Valenca |
---|---|
Information provided by: | Faculdade de Medicina de Valenca |
ClinicalTrials.gov Identifier: | NCT00591994 |
Tinnitus is defined as the perception of sound in the absence of a external source. About 15 % of the population is believed to experience tinnitus and for about 20 % of them it may become a very serious problem. Total comprehension of tinnitus pathophysiology has not yet been achieved, but modern theories focus in brain hyperactivity following inner ear damage, with involvement of various neurotransmitters. Piribedil,a dopamin agonist, has been used to treat tinnitus, focusing in dopamine release, which is inhibitory. Electrophysiological methods,like acoustic otoemissions and electrocochleography may reveal the changes in peripherical and central auditory pathways and help to choose the specific patients who could benefit from piribedil treatment.
Condition | Intervention |
---|---|
Tinnitus |
Drug: piribedil |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography |
Enrollment: | 100 |
Study Start Date: | November 2006 |
Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Brazil, RJ | |
OTOSUL,Otorrinolaringologia Sul-Fluminense | |
Volta Redonda, RJ, Brazil, 27255-650 |
Study Chair: | Ricardo R Figueiredo, M.D.,M.Sc | Faculdade de Medicina de Valença |
Principal Investigator: | Andréia A Azevedo, M.D. | OTOSUL,Otorrinolaringologia Sul-Fluminense |
Responsible Party: | OTOSUL ( Andréia Aparecida de Azevedo, M.D. ) |
Study ID Numbers: | OTOSUL 01/2007, FMV 01/2006 |
Study First Received: | December 26, 2007 |
Last Updated: | March 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00591994 |
Health Authority: | Brazil: Ministry of Health |
tinnitus piribedil acoustic otoemissions ECoG |
Signs and Symptoms Sensation Disorders Hearing Disorders Dopamine Otorhinolaryngologic Diseases |
Piribedil Neurologic Manifestations Ear Diseases Tinnitus |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Therapeutic Uses Physiological Effects of Drugs Nervous System Diseases |
Antiparkinson Agents Dopamine Agents Dopamine Agonists Central Nervous System Agents Pharmacologic Actions |